Member Info for kentan

Those strange small trades show up again today ... notice they are repeated in the same sequences.
What is going on?

Perhaps those who have obtained the 1.8m shares (valued today at £20.7k) have been told that they will be worth considerably more in the near future when the SP begins to fly on favourable research findings ...
In other words ... give us a good report and we will all be well rewarded.

This looks promising ... like it when an RNS starts with "... delighted to announce"
Nelson Law (Chairman):
"We are very proud to have launched England Pie on Tmall.com. This move aligns with our strategy to build a bridge between European merchants of desirable, high-end goods and sophisticated Chinese consumers with global taste. England Pie on Tmall.com is the ideal infrastructure to realise that goal."
Should propel the SP upwards ...

After nearly hitting $44 a week ago on promising news of clinical trials, Portage (PRTG:NASDAQ) yesterday dropped 25% from their overnight price to $25.95 on news of a public offering of 1 million new shares at $23.
Portage intends to use the gross proceeds of $23,000,000 before deducting underwriting
discounts and offering expenses (without giving effect to any exercise of the underwriters’ option
to purchase additional ordinary shares, if any), for the acceleration of its PORT-2 and PORT-3
clinical programs, to prepare the next products to enter the clinic, and for working capital and
other general corporate purposes.
Quite a bombshell with the offer price discounted so heavily.
https://www.portagebiotech.com/wp-content/uploads/2021/06/Portage_Pricing-6.24.2021-FINAL.pdf

News has emerged in the past week that Sheikh Ahmed bin Dalmook al Maktoum and his business partner, Umar Farooq Zahoor, are again immersed in controversy with the overpriced sale of Russian made "Sputnik V" coronavirus vaccines to Ghana, with whom they were previously accused of selling overpriced Electricity generating plants in 2015 after collaborating with the then President, John Mahama, in a very questionable deal.
https://www.ghanaweb.com/GhanaHomePage/NewsArchive/Sheik-Al-Maktoum-The-Dubai-royal-who-allegedly-sold-overpriced-Sputnik-V-vaccines-to-Ghana-1282471
He is still in association with Oracle Power (ORCP) but it seems they will now be distancing themselves from him and ending their collaboration because of the ongoing scandals.
We are all familiar with his chicanery after the "MXO/ADM" debacle ... so why is the company still bearing his initials as their title?
The countless MoU's he has signed with African & Asian countries are now seen as worthless posturing and totally lack credibility and he is totally discredited within the oil industry.
Any suggestions for the rename?

News has emerged in the past week that Sheikh Ahmed bin Dalmook al Maktoum and his business partner, Umar Farooq Zahoor, are again immersed in controversy with the overpriced sale of Russian made "Sputnik V" coronavirus vaccines to Ghana, with whom they were previously accused of selling overpriced Electricity generating plants in 2015 after collaborating with the then President, John Mahama, in a very questionable deal.
https://www.ghanaweb.com/GhanaHomePage/NewsArchive/Sheik-Al-Maktoum-The-Dubai-royal-who-allegedly-sold-overpriced-Sputnik-V-vaccines-to-Ghana-1282471
Are Oracle Power now seeing the connection to the Sheikh's Private Office as being a possible embarrassment and are taking steps to distance themselves from him ...
https://www.sharesmagazine.co.uk/news/market/LSE20201201070003_3798497/Update-on-Non-Binding-MoU-with-HH-Private-Office
As was seen with the "ADM Energy" debacle (the company still bears his initials) he is now famous for his empty promises and has been discredited within the oil industry, most of the many MoU's he has signed with African & Asian countries are now seen as worthless posturing and lack credibility.
His association with ORCP is now detrimental to the SP and his early removal from association with the company would be of benefit before any further scandalous news emerges.

Encouraging results of preliminary trial has sparked a rise on NASDAQ.
Has risen from a low of $26.54 (since listing on NASDAQ) on 25th May 2021 to close at a consolidated $39.00 last night (up 48.7% for the period).
We can expect some profit-taking before the continued rise upwards on promising results of trials ... $50+ is easily possible and expected.
Our only problem with selling is it is still by matched bargains, so the spread can be very large, but once volume increases there is the possibility to state a minimum realistic price for bids for larger packages of shares and hope they are bought.

Encouraging to see David Archer accumulating shares again (450k costing £14,395) after his fire sale last December 2020 to support his hotel venture in Austria (2m shares sold for £50,950), plus the Chairman and McGurty participating in the recent 4p fundraise.
Hope this is the start of a promising few months with plenty of news on the horizon.

Covid impact aside, it is a bit like the curate's egg ... good in parts.
As per usual, plenty of promise (ie. "jam tomorrow") for both projects (Portugal & Mozambique), but notice how they have glossed over the disaster that was Oman, which has cost the company dear.
Now heavily reliant on the demand and strength of lithium and ilmenite prices being maintained.
I have been here since 2014 when Moz was going to be the guiding light (now somewhat dimmed), Oman has come and gone and MdeB is now the proposed star of the show ... in all cases, so far nothing has come out of the ground.
We live in hope.

Using the acronyms used in the recent TV Series ...
Neil is our "CHIS"
Allan Syms is part of the "OCG" along with Dr Dawn Coverley under the control of the "Yorkshire Cancer Research" Group (YCRG))
Antos Glogowski is "H" or the "Fourth Man"
I am requesting a "Sit Rep" on "CIZ" and a "PM" on "BOU"
RIP ... "AIM" now for a full listing on "FOOTSIE"

I am not familiar with Richard James perfumes for men, but those 2 little words (Saville Row) in the title give a lot of credence to those familiar with "high end" products that the rich Chinese & Asian wealthy crave for.
Next time I am in Liberty's (London) department store I will sniff them out, I usually only buy "Creed" and "Comme De Garcon" Eau de Perfume & Eau de Toilette products when on offer, they are very expensive. I notice the Japanese, Chinese & Asian tourists stuff their bags with them to take back home, so upmarket perfume and grooming products are high on their list of purchases.
With Richard James' perfumiers links to the established "Burberry" & "Pierre Cardin" brands, there could be room for further contracts for Sealand in the luxury goods sector where marketing is key to promotion and distribution to the aspiring Far East population ... this all bodes well for the future for SCGL.

Could have been a shakeout exercise by MM's, with big spreads, to get their hands on some stock before it really takes off ... perhaps from those that have been sitting on these for over 12 months, bought on the drop to below 3p (like me) and waiting for them to realise their true worth. Patience has worn thin for some since the last update on November 30th with very little news or information afterwards ... for what it's worth, my advice is to sit tight and buy on any drops in the hope we will all be rewarded.

I have been informed by "Etoro" that they cannot deal Portage Biotech (PRTG) shares on NASDAQ as there is no specific bid and ask at the current volumes. As has been said before, they are mainly an over the counter share with matched bargains so is something Etoro are unable to do (at present) ... that is, until they issue more stock and become a fully-fledged share like Biohaven (BHVN) has become, with high daily liquidity.
Most of the recorded transactions so far for PRTG on NASDAQ are for parcels of 100 shares, but there is no indication of whether they are buys or sells.

I am exploring the possibility of being able to deal in PRTG on NASDAQ via the "Etoro" trading platform with low expenses and easy transfer of proceeds to UK ...
Currently, "Etoro" doesn't recognise the newly listed PRTG ticker on NASDAQ, but shouldn't be long now before they update their system.
Then it will be possible to buy and sell PRTG, providing the spread isn't too large.
Whatever happens, you must download the W8-BEN form and submit it, to be able to realise proceeds to UK exempt from higher US tax charges.

https://investingnews.com/news/biotech-investing/portage-biotech-divests-portage-pharmaceuticals-limited-to-juvenescence-ltd/
Reasons for the listing on NASDAQ starting to take shape.
Could be the start of the big moves planned by Jim Mellon & Co. ... leading to an IPO for Juvenescence on the NASDAQ and/or London market.

Portage Biotech opened at $37.50 on NASDAQ

https://www.nasdaq.com/market-activity/stocks/prtg/real-time

A fellow independent non-executive director of Regent Pacific Group Ltd is ... Julie Wild Oates
You couldn't make it up.

Have to laugh at his Hong Kong Stock Exchange quoted Regent Pacific Group Ltd where he has been non-executive chairman since 2002, he is the majority shareholder with a holding of 10.1% of the issued stock ... up 10.64% today to 0.26HK$
Noted for their Premature Ejaculation Drug (launched in 2019) and acquisition of Deep Longevity in 2020.

Regent Pacific Group Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sales of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in ageing research and developing artificial intelligence (AI) models and tool products related to ageing research. It offers ageing and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and ageing research institutions.
A smart cookie is our Jim, makes sure he plays the long game and doesn't come too soon.

All is revealed:
https://youtu.be/r0dcv6GKNNw
Now you know ... LoL!!

If you want to buy American shares you need to send a completed W-8BEN form to your broker (normally they will be able to provide the form and show you how to complete it). If you don’t then your dividends and interest will suffer 30% withholding tax, rather than 15%, and some overzealous brokers may even keep back 30% of any sale proceeds if they haven’t got a W-8BEN.

You can reclaim the excess tax but be warned. This means dealing directly with America’s Internal Revenue Service so I’d recommend completing the W-8BEN to avoid having to make a reclaim. W-8BENs remain valid until the first 31 December that occurs after the third anniversary of you signing the form. So a form signed on 1 March 2021 would remain valid until 31 December 2024, and so on.